Vytrus Biotech

Vytrus Biotech Diluted EPS

The Diluted Earnings per Share of Vytrus Biotech (VYT.MC) as of Oct 30, 2026 is 0.39 EUR. In the previous year, Diluted Earnings per Share was 0.14 EUR — a change of 183.99% (higher).

Diluted EPS

0.39EUR

YoY

183.99%

Last updated:

Diluted Earnings per Share of Vytrus Biotech is 2025 0.39 EUR. Diluted Earnings per Share of Vytrus Biotech was 2024 0.14 EUR. It decreases by 183.99% higher compared to the previous year.

The Vytrus Biotech Diluted EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Diluted EPS
Date
Diluted EPS
Jan 1, 2018
-0.01 EUR
Jan 1, 2019
-0.01 EUR
Jan 1, 2020
0.03 EUR
Jan 1, 2021
0.06 EUR
Jan 1, 2022
0.09 EUR
Jan 1, 2023
0.07 EUR
Jan 1, 2024
0.14 EUR
Jan 1, 2025
0.39 EUR
The Vytrus Biotech Diluted EPS history
YEARDiluted EPSYoY
0.39EUR+183.99%
0.14EUR+87.17%
0.07EUR-18.02%
0.09EUR+47.70%
0.06EUR+107.48%
0.03EUR-382.91%
-0.01EUR+64.52%
-0.01EUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Vytrus Biotech Stock analysis

What does Vytrus Biotech do? Vytrus Biotech SA, based in Terrassa, Spain, develops cosmetic active ingredients using plant stem cell technology. The company, listed on 24 March 2022, focuses on creating high-value natural active ingredients for the cosmetics and pharmaceutical sectors through industrial-scale production of bioactive molecules derived from plant cell cultures. With 29 employees, Vytrus targets dermo-cosmetics, veterinary medicine, and functional food, achieving over 99% resource savings compared to traditional methods. Vytrus Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vytrus Biotech stock

Diluted Earnings per Share of Vytrus Biotech is 0.39 EUR in 2025.

Diluted Earnings per Share of Vytrus Biotech changed from 0.14 EUR to 0.39 EUR, representing a 183.99% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Diluted Earnings per Share Vytrus Biotech since 2006 – with annual values, charts, and detailed analysis.

Diluted EPS accounts for all potential shares from options, warrants, and convertible securities. It provides a more conservative per-share earnings measure.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Vytrus Biotech

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Vytrus Biotech